Stay updated on Perampanel in Focal Status Epilepticus Clinical Trial

Sign up to get notified when there's something new on the Perampanel in Focal Status Epilepticus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perampanel in Focal Status Epilepticus Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy of add-on Perampanel in Focal Motor Status Epilepticus, a study focusing on the treatment of focal motor status epilepticus with a new drug called Perampanel.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:25.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that patients must be aged 18 or above with focal motor status epilepticus and meet certain health conditions. Previously, no information was provided in this section.
    Difference
    19%
    Check dated 2024-05-22T21:26:17.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:44:07.000Z thumbnail image

Stay in the know with updates to Perampanel in Focal Status Epilepticus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perampanel in Focal Status Epilepticus Clinical Trial page.